PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with an extremely poor prognosis. There is an urgent need to identify new therapeutic targets and also understand the mechanism of PDAC progression that leads to aggressiveness of the disease. To find therapeutic targets, we analyzed da...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Sumit, Chakravarthi, Balabhadrapatruni V.S.K., Kim, Hyung-Gyoon, Gupta, Nirzari, Hale, Kevin, Balasubramanya, Sai Akshaya Hodigere, Oliver, Patsy G., Thomas, Dafydd G., Eltoum, Isam-Eldin A., Buchsbaum, Donald J., Manne, Upender, Varambally, Sooryanarayana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229293/
https://www.ncbi.nlm.nih.gov/pubmed/32422575
http://dx.doi.org/10.1016/j.tranon.2020.100776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229293/
https://www.ncbi.nlm.nih.gov/pubmed/32422575
http://dx.doi.org/10.1016/j.tranon.2020.100776

Ejemplares similares